Blend Overview

GLOW is a peptide blend composed of GHK-Cu, BPC-157, and TB-500 in a 50mg / 10mg / 10mg ratio. GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, BPC-157 is a 15-amino-acid peptide sequence, and TB-500 is the N-acetylated 17-23 fragment of thymosin beta 4.

This material is supplied as a laboratory research reagent intended for controlled experimental settings, including in vitro assay development, peptide analytics, and other non-clinical investigative workflows involving the listed components.

Product Information

Product Type: Peptide blend
Blend Name: GLOW
Blend Ratio: GHK-Cu (50mg) / BPC-157 (10mg) / TB-500 (10mg)
Components: GHK-Cu, BPC-157, TB-500
Component 1 Sequence: Gly-His-Lys(Cu²⁺)
Component 2 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Component 3 Sequence: N-Acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln
Component 1 Molecular Formula: C₁₄H₂₂N₆O₄Cu
Component 2 Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Component 3 Molecular Formula: C₃₈H₆₈N₁₀O₁₄
Component 1 Molecular Weight: 401.91 g/mol
Component 2 Molecular Weight: 1419.5 g/mol
Component 3 Molecular Weight: 889.02 g/mol
Component 1 CAS Number: 89030-95-5
Component 2 CAS Number: 137525-51-0
Component 3 CAS Number: 885340-08-9
Purity: 99.40%

Research Applications

Component-attributable literature for the peptides in this blend includes in vitro fibroblast growth and growth-factor expression work involving GHK-Cu, tendon fibroblast migration and explant outgrowth studies involving BPC-157, and high-resolution mass spectrometry, metabolite profiling, and bioanalytical detection workflows involving TB-500 and related short-fragment metabolites.

In vitro dermal fibroblast growth studies involving GHK-Cu
Growth-factor expression assays in fibroblast culture involving GHK-Cu
Ex vivo tendon explant outgrowth studies involving BPC-157
In vitro tendon fibroblast migration assays involving BPC-157
Cell survival studies under stress conditions involving BPC-157
High-resolution mass spectrometric identification of Ac-LKKTETQ
TB-500 metabolite profiling in serum, urine, or related matrices
LC-MS/UHPLC method development for TB-500 and short-fragment metabolites